Award
Delivery Order #SPE2D326F124Q
Pfizer to Supply Tranexamic Acid Injection Under DLA Delivery Order
Buyer
Defense Logistics Agency
Award Amount
$134.76
Ceiling
$134.76
Awarded
May 15, 2026
Period of Performance
May 15, 2026 – May 18, 2026
Identifier
SPE2D326F124Q
NAICS
325412
This delivery order is placed under the Defense Logistics Agency’s long-term pharmaceutical supply agreement with Pfizer Inc., a pharmaceutical manufacturer. It procures Cyklokapron (tranexamic acid) injection, supplied as 1,000 mg in a 10 mL vial, for delivery in New York. The medicine is used to help control bleeding; the order supports access to pharmaceutical supplies for government medical needs. The scope shown is limited to this product and delivery, with no additional services or subcontractors reported. The order is associated with Pfizer’s parent indefinite-delivery contract for pharmaceutical manufacturing and distribution, which runs over a multi-year period. The parent award is described as competitively awarded; the order-level data does not specify whether this individual order involved a separate competition or a sole-source justification. The delivery order was recently issued for a brief performance period. No acquisition program or original solicitation details are provided.
Description
4571850221!CYKLOKAPRON 1,000 MG/10 ML VL 10ML